Determining ICU Staffs Conceptions, Opinions, Views, Experiences and Reflection of Brain Death and Organ Donation (DISCOVER)

June 15, 2026 updated by: University Hospital, Basel, Switzerland
The study aims to gather information regarding the individual perceptions, opinions, beliefs, and conceptual understanding of healthcare professionals working in the intensive care units at the University Hospital Basel, the Cantonal Hospital Aarau and the Cantonal Hospital Baselland, and to determine associations of individual beliefs, personal, educational, and professional experiences with individual perceptions, opinions, and conceptual understanding regarding brain death and organ donation.

Study Overview

Status

Completed

Conditions

Detailed Description

To achieve the study objectives, the investigator will employ a questionnaire-based survey administered to the consenting/participating nurses and physicians. The questionnaire will address various aspects related to personal background, religious affiliation, beliefs about life after death, the conceptual understanding of brain death and organ donation, as well as experiences and opinions related to these topics.

Study Type

Observational

Enrollment (Actual)

338

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Basel, Switzerland, 4031
        • University Hospital Basel

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Eligible healthcare professionals in the ICU at the University Hospital Basel, the Cantonal Hospital Aarau and the Cantonal Hospital Baselland

Description

Inclusion Criteria:

  • Consenting nurses and physicians currently working in the intensive care units (ICU) at the University Hospital Basel, the Cantonal Hospital Aarau and the Cantonal Hospital Baselland
  • Only nurses and physicians consenting to participate will be included

Exclusion Criteria:

  • Nurses and physicians not currently working (any more) in the intensive care unit (ICU) at the University Hospital Basel, the Cantonal Hospital Aarau or the Cantonal Hospital Baselland
  • Nurses and physicians who do not consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Information on individual perceptions regarding brain death and organ donation
Time Frame: at baseline
Descriptive analyses will be performed to identify individual perceptions
at baseline
Information on individual opinions regarding brain death and organ donation
Time Frame: at baseline
Descriptive analyses will be performed to identify individual opinions
at baseline
Information on individual beliefs regarding brain death and organ donation
Time Frame: at baseline
Descriptive analyses will be performed to identify individual beliefs
at baseline
Information on conceptual understanding regarding brain death and organ donation
Time Frame: at baseline
Descriptive analyses will be performed to identify conceptual understanding
at baseline
Identification of interprofessional variations
Time Frame: at baseline
Descriptive analyses will be performed to identify interprofessional variations
at baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Raoul C. Sutter, Prof. Dr., University Hospital, Basel, Switzerland

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 14, 2024

Primary Completion (Actual)

April 30, 2025

Study Completion (Actual)

April 30, 2025

Study Registration Dates

First Submitted

October 10, 2024

First Submitted That Met QC Criteria

October 10, 2024

First Posted (Actual)

October 15, 2024

Study Record Updates

Last Update Posted (Actual)

June 17, 2026

Last Update Submitted That Met QC Criteria

June 15, 2026

Last Verified

June 1, 2026

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe